New solution may keep donor hearts safer for kids

NCT ID NCT06032195

Recruiting now Disease control Sponsor: Dr. F. Köhler Chemie GmbH Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study tests a new liquid (Custodiol-N) used to preserve donor hearts before transplant in children. 15 children receiving their first heart transplant will be randomly assigned to get a heart stored in either the new or standard solution. The main goal is to check if the new solution is safe by tracking side effects and vital signs.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for END-STAGE HEART FAILURE are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

advanced heart failure

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

HEART TRANSPLANTATION

Contacts and locations

Locations

Deutsches Herzzentrum der Charité
RECRUITING

Berlin, 13353, Germany
Klinikum der Universität München (LMU), Klinik und Poliklinik für Herzchirurgie, Chirurgische Klinik
RECRUITING

München, 81377, Germany
Universitätsklinikum Gießen (UKGM), Kinderherzzentrum, Klinikum für Kinderherzchirurgie
RECRUITING

Giessen, 35385, Germany

More trials for these conditions

Other studies related to the condition(s) this trial covers.